Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176655 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
A Phase 2 study, sponsored by Cady, Roger, M.D..
- Completed
- Registry status
- Phase 2
- Development phase
- 31
- Enrollment target
NCT02176655 is a Phase 2 study that has completed, run by Cady, Roger, M.D.. The registered enrollment target is 31 participants.
The verdict
NCT02176655, a Phase 2 study, has completed, sponsored by Cady, Roger, M.D..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study proposes to compare the efficacy of sumatriptan and aspirin to placebo as an acute abortive treatment for delayed alcohol induced headache in adult subjects.
Interventions
- DRUG Placebo
- DRUG VVD-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02176655
The ClinicalTrials.gov registry entry for NCT02176655 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cady, Roger, M.D., which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02176655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02176655 about?
NCT02176655 is a clinical study titled "Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches". This study proposes to compare the efficacy of sumatriptan and aspirin to placebo as an acute abortive treatment for delayed alcohol induced headache in adult subjects.
What is the current status of trial NCT02176655?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2014-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02176655?
The interventions under investigation include: Placebo (DRUG), VVD-101 (DRUG).
Who is sponsoring clinical trial NCT02176655?
This trial is sponsored by Cady, Roger, M.D., which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.